Embolization of metastatic neuroendocrine tumor resulting in clinical manifestations of syndrome of inappropriate secretion of antidiuretic hormone. uri icon

Overview

abstract

  • Complications after hepatic artery embolization are usually minor and transient. This report describes a patient with a pancreatic neuroendocrine tumor with hepatic metastases who repeatedly developed clinical findings of syndrome of inappropriate secretion of antidiuretic hormone with hyponatremia (sodium < 130 mEq/L), low plasma osmolarity (< 275 mOsm/kg), and high urine osmolarity (> 500 mOsm/kg) after every session of hepatic artery embolization.

publication date

  • April 1, 2015

Research

keywords

  • Chemoembolization, Therapeutic
  • Inappropriate ADH Syndrome
  • Liver Neoplasms
  • Neuroendocrine Tumors

Identity

PubMed Central ID

  • PMC5066575

Scopus Document Identifier

  • 84925354993

Digital Object Identifier (DOI)

  • 10.1016/j.jvir.2014.11.032

PubMed ID

  • 25805538

Additional Document Info

volume

  • 26

issue

  • 4